Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy

Author: Marshall John   McEachern Kerry   Chuang Wei-Lien   Hutto Elizabeth   Siegel Craig   Shayman James   Grabowski Greg   Scheule Ronald   Copeland Diane   Cheng Seng  

Publisher: Springer Publishing Company

ISSN: 0141-8955

Source: Journal of Inherited Metabolic Disease, Vol.33, Iss.3, 2010-06, pp. : 281-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content